180 Wealth Advisors LLC Raises Holdings in Veru Inc. (NASDAQ:VERU)

180 Wealth Advisors LLC raised its position in Veru Inc. (NASDAQ:VERU) by 16.6% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 199,100 shares of the company’s stock after purchasing an additional 28,350 shares during the quarter. 180 Wealth Advisors LLC owned 0.14% of Veru worth $185,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Worth Venture Partners LLC acquired a new stake in Veru during the 4th quarter worth approximately $616,000. AIGH Capital Management LLC bought a new position in Veru during the fourth quarter worth $2,476,000. ADAR1 Capital Management LLC acquired a new position in Veru in the fourth quarter worth $360,000. Octagon Capital Advisors LP bought a new stake in Veru during the fourth quarter valued at $2,736,000. Finally, Perceptive Advisors LLC raised its holdings in shares of Veru by 412.4% during the fourth quarter. Perceptive Advisors LLC now owns 5,584,699 shares of the company’s stock worth $4,021,000 after purchasing an additional 4,494,821 shares during the period. 47.16% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several research firms have recently commented on VERU. HC Wainwright reaffirmed a “buy” rating and issued a $3.00 price target on shares of Veru in a report on Monday, May 13th. B. Riley began coverage on shares of Veru in a report on Tuesday, May 14th. They issued a “buy” rating and a $5.00 price objective for the company.

Veru Stock Performance

NASDAQ VERU traded up $0.04 on Thursday, reaching $0.84. The company’s stock had a trading volume of 533,357 shares, compared to its average volume of 2,065,860. The firm’s 50 day moving average is $0.88 and its two-hundred day moving average is $0.90. The stock has a market cap of $122.96 million, a PE ratio of -2.35 and a beta of -0.44. Veru Inc. has a twelve month low of $0.36 and a twelve month high of $1.92.

Veru (NASDAQ:VERU) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.01). The firm had revenue of $3.95 million for the quarter, compared to analyst estimates of $3.50 million. Veru had a negative net margin of 376.38% and a negative return on equity of 115.99%. During the same quarter in the prior year, the firm earned ($0.13) EPS. Equities research analysts anticipate that Veru Inc. will post -0.27 EPS for the current fiscal year.

Insider Buying and Selling

In other Veru news, CEO Mitchell Shuster Steiner sold 63,379 shares of Veru stock in a transaction on Friday, May 24th. The shares were sold at an average price of $1.23, for a total transaction of $77,956.17. Following the completion of the sale, the chief executive officer now owns 6,942,709 shares of the company’s stock, valued at approximately $8,539,532.07. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Over the last three months, insiders sold 97,949 shares of company stock worth $124,044. 14.20% of the stock is owned by company insiders.

Veru Company Profile

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.